Sofgen Pharma S.A. (PROCF)
OTCMKTS · Delayed Price · Currency is USD
0.0251
0.00 (0.00%)
Jul 24, 2026, 9:30 AM EST
Sofgen Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
| 58 | 264 | 459 | 592 | 1,100 | 260 | |
Market Cap Growth | -63.06% | -42.51% | -22.48% | -46.15% | 323.09% | 8.29% |
Enterprise Value | 334 | 535 | 731 | 818 | 1,220 | - |
Last Close Price | 0.03 | 2.34 | 4.07 | 5.25 | 9.75 | 10.40 |
Price Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
PE Ratio | - | - | 11.38 | 16.40 | - | - |
Forward PE | - | 4.79 | 14.09 | 12.21 | 22.67 | - |
PS Ratio | 0.16 | 0.71 | 1.08 | 1.47 | 2.73 | 0.78 |
PB Ratio | -1.12 | -5.07 | -623.90 | -15.95 | -15.72 | -1.02 |
P/FCF Ratio | 0.85 | 3.82 | 5.26 | - | 54.96 | 4.11 |
P/OCF Ratio | 0.66 | 2.99 | 4.27 | 38.09 | 31.03 | 3.67 |
PEG Ratio | - | 0.32 | 0.32 | 0.29 | - | - |
EV Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
EV/Sales Ratio | 0.89 | 1.43 | 1.72 | 2.03 | 3.02 | - |
EV/EBITDA Ratio | - | - | 10.48 | 18.30 | 669.77 | - |
EV/EBIT Ratio | - | - | 11.93 | 23.98 | - | - |
EV/FCF Ratio | 4.83 | 7.75 | 8.37 | - | 60.93 | - |
Financial Efficiency
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Debt / Equity Ratio | -5.89 | -5.89 | -424.80 | -8.09 | -3.62 | -1.78 |
Debt / EBITDA Ratio | - | - | 4.12 | 5.89 | 41.92 | 5.71 |
Debt / FCF Ratio | 4.44 | 4.44 | 3.58 | - | 12.66 | 7.19 |
Net Debt / Equity Ratio | -5.31 | -5.31 | -401.00 | -6.93 | -2.59 | -1.77 |
Net Debt / EBITDA Ratio | -14.45 | -14.45 | 4.23 | 5.75 | 99.54 | 6.01 |
Net Debt / FCF Ratio | 4.00 | 4.00 | 3.38 | -33.81 | 9.06 | 7.12 |
Asset Turnover | 0.85 | 0.85 | 0.93 | 0.90 | 1.00 | 0.95 |
Inventory Turnover | 2.04 | 2.04 | 1.84 | 1.85 | 2.39 | 2.17 |
Quick Ratio | 0.29 | 0.29 | 0.36 | 0.42 | 0.55 | 0.47 |
Current Ratio | 0.52 | 0.52 | 0.64 | 0.72 | 0.80 | 0.77 |
Return on Assets (ROA) | -4.03% | -4.03% | 8.37% | 4.78% | -1.40% | 11.30% |
Return on Invested Capital (ROIC) | -164.13% | -164.13% | 112.96% | 34.35% | -8.48% | -741.90% |
Return on Capital Employed (ROCE) | 673.10% | 673.10% | 157.30% | 60.70% | -9.60% | 52.60% |
Yields
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Earnings Yield | -117.05% | -25.87% | 8.79% | 6.10% | -9.73% | -4.02% |
FCF Yield | 118.34% | 26.16% | 19.01% | -1.28% | 1.82% | 24.32% |
Buyback Yield / Dilution | 0.83% | 0.73% | 0.10% | -3.02% | -1.04% | - |